PACB

Pacific Biosciences of California, Inc.

5.19 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Pacific Biosciences of California, Inc. stock is down -23.11% since 30 days ago. The next earnings date is Apr 30, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 35.71% of the previous 13 March’s closed higher than February. In the last 10 Unusual Options Trades, there were 5 PUTs, 5 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
15 Feb 20:51 15 Mar, 2024 7.00 PUT 2000 541
16 Feb 16:35 19 Apr, 2024 6.00 CALL 1000 0
21 Feb 15:29 21 Jun, 2024 5.00 PUT 500 152
21 Feb 16:05 15 Mar, 2024 7.00 PUT 133 2532
21 Feb 16:05 15 Mar, 2024 7.00 PUT 270 2532
21 Feb 16:05 15 Mar, 2024 7.00 PUT 324 2532
22 Feb 16:18 15 Mar, 2024 6.00 CALL 1750 6914
27 Feb 15:44 18 Oct, 2024 5.00 CALL 500 25
27 Feb 18:36 17 Jan, 2025 5.00 CALL 212 207
27 Feb 20:31 19 Apr, 2024 6.00 CALL 1000 1676

About Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. PacBio's Systems conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow.